Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)
1.140
0.00 (0.00%)
Apr 29, 2026, 3:57 PM HKT
HKG:2348 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 564.94 | 326 | 358.06 | 358.18 | Upgrade
|
| Depreciation & Amortization | - | 104.48 | 81.85 | 64.39 | 56.36 | Upgrade
|
| Other Amortization | - | 2.14 | 2.05 | 2.02 | 1.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 4.21 | 0.26 | -38.84 | -69.11 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -292.89 | -5.68 | -7.2 | -5.56 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 3.7 | 40.93 | 61.91 | 46.42 | Upgrade
|
| Stock-Based Compensation | - | -0.51 | -1.02 | -4.91 | 4.33 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -1.99 | 0.69 | 2.44 | - | Upgrade
|
| Other Operating Activities | - | 5.72 | -128.93 | 1.77 | -3.9 | Upgrade
|
| Change in Accounts Receivable | - | 40.73 | 73.38 | -79.82 | -27.07 | Upgrade
|
| Change in Inventory | - | -141.01 | 19.7 | -42.37 | 39.45 | Upgrade
|
| Change in Accounts Payable | - | 56.22 | -61.91 | 80.86 | -12.11 | Upgrade
|
| Change in Unearned Revenue | - | 3.36 | -0.3 | -0.3 | -0.3 | Upgrade
|
| Change in Other Net Operating Assets | - | -128.89 | -8.62 | 36.26 | 5.28 | Upgrade
|
| Operating Cash Flow | - | 220.2 | 338.4 | 434.27 | 393.14 | Upgrade
|
| Operating Cash Flow Growth | - | -34.93% | -22.07% | 10.46% | 29.79% | Upgrade
|
| Capital Expenditures | - | -126.04 | -199.55 | -204.37 | -313.07 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.77 | 0.63 | 0.39 | 1.6 | Upgrade
|
| Cash Acquisitions | - | - | - | -8.64 | - | Upgrade
|
| Divestitures | - | - | - | 20.8 | 73.77 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -49.58 | -12.46 | -21.3 | -89.96 | Upgrade
|
| Investment in Securities | - | 223.76 | -133.31 | -25.5 | 64.7 | Upgrade
|
| Other Investing Activities | - | 156.27 | -42.88 | 63.6 | -21.24 | Upgrade
|
| Investing Cash Flow | - | 205.17 | -387.57 | -175.01 | -284.2 | Upgrade
|
| Short-Term Debt Issued | - | 224.86 | 120.06 | 6.43 | 21.01 | Upgrade
|
| Total Debt Issued | - | 224.86 | 120.06 | 6.43 | 21.01 | Upgrade
|
| Short-Term Debt Repaid | - | -300 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -1.31 | -1.56 | -0.44 | -1.04 | Upgrade
|
| Total Debt Repaid | - | -301.31 | -1.56 | -0.44 | -1.04 | Upgrade
|
| Net Debt Issued (Repaid) | - | -76.45 | 118.51 | 6 | 19.97 | Upgrade
|
| Issuance of Common Stock | - | 1.37 | 1.17 | 0.35 | 2.19 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -15.53 | Upgrade
|
| Common Dividends Paid | - | -111.2 | -117.08 | -99.54 | -143.91 | Upgrade
|
| Other Financing Activities | - | -3.16 | -0.53 | 0.5 | 7.53 | Upgrade
|
| Financing Cash Flow | - | -189.44 | 2.07 | -92.7 | -129.75 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 12.92 | 2.25 | 7.39 | 0.08 | Upgrade
|
| Net Cash Flow | - | 248.85 | -44.86 | 173.94 | -20.74 | Upgrade
|
| Free Cash Flow | - | 94.16 | 138.85 | 229.9 | 80.07 | Upgrade
|
| Free Cash Flow Growth | - | -32.19% | -39.61% | 187.12% | -51.12% | Upgrade
|
| Free Cash Flow Margin | - | 8.88% | 12.06% | 17.99% | 6.87% | Upgrade
|
| Free Cash Flow Per Share | - | 0.06 | 0.09 | 0.15 | 0.05 | Upgrade
|
| Cash Interest Paid | - | 3.16 | 0.53 | - | 0.54 | Upgrade
|
| Cash Income Tax Paid | - | 76.74 | 62.52 | 63.19 | 65.16 | Upgrade
|
| Levered Free Cash Flow | - | -18.43 | -217.18 | 365.17 | -1.67 | Upgrade
|
| Unlevered Free Cash Flow | - | -16.17 | -216.56 | 365.4 | -1.27 | Upgrade
|
| Change in Working Capital | - | -169.6 | 22.26 | -5.36 | 5.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.